Latest Articles

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers^1,2

The pathophysiology of ITP stems from complex immune dysregulation drives thrombocytopenia and inflammation

The pathophysiology of ITP stems from complex immune dysregulation drives thrombocytopenia and inflammation

Rilzabrutinib a BTK inhibitor

Rilzabrutinib a BTK inhibitor

Complex immune dysregulation impact on QoL

Complex immune dysregulation impact on QoL

Interplay between the innate and adaptive immunity

Interplay between the innate and adaptive immunity 

Early Intervention and Disease Modification in Atopic Dermatitis

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Saudi Health Promotion and Prevention Guideline for Diabetes Mellitus

Effective Treatment Simplification

Prof. Robert Ritzel, Division of Endocrinology, Munich and University of Heidelberg, Germany, presents effective treatment simplification for people with T2D using fixed ration combination of iGlarLixi.